Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-060547

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mark K Bennett
Officer — SR. VP, RESEARCH
Period of report
Jul 9, 2015
Accepted (ET)
Jul 10, 2015 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 8, 2015M3,039$0.48A4,175D
Common StockF1Jul 8, 2015M2,688$0.48A6,863D
Common StockF1Jul 8, 2015M4,726$0.96A11,589D
Common StockF1Jul 8, 2015M7,912$2.64A19,501D
Common StockF2holding———31,554IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$0.48Jul 8, 2015M3,039D—Dec 13, 2021Common Stock3,0391,217D
Stock Option (Right to Buy)F4$0.48Jul 8, 2015M2,688D—Jun 12, 2022Common Stock2,6882,419D
Stock Option (Right to Buy)F5$0.96Jul 8, 2015M4,726D—May 22, 2023Common Stock4,72610,869D
Stock Option (Right to Buy)F6$2.64Jul 8, 2015M7,912D—Dec 16, 2023Common Stock7,91223,747D

Explanation of responses